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High Pressure Induces Superoxide Production in Isolated
Arteries Via Protein Kinase C–Dependent Activation of
NAD(P)H Oxidase
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Background—Oxidative stress seems to be present in all forms of hypertension. Thus, we tested the hypothesis that high
intraluminal pressure (Pi) itself, by activating vascular oxidases, elicits increased superoxide (O2·) production
interfering with flow-induced dilation.
Methods and Results—Isolated, cannulated rat femoral arterial branches were exposed in vitro (for 30 minutes) to normal
Pi (80 mm Hg) or high Pi (160 mm Hg). High Pi significantly increased vascular O2· production (as measured by
lucigenin chemiluminescence and ethidium bromide fluorescence) and impaired endothelium-dependent dilations to
flow; these effects could be reversed by superoxide dismutase. Administration of the NAD(P)H oxidase inhibitor
diphenyleneiodonium, apocynin, the protein kinase C (PKC) inhibitor chelerythrine or staurosporin or the removal of
extracellular Ca2 during high Pi treatment prevented the increases in O2· production, whereas administration of
losartan or captopril had no effect. High Pi resulted in significant increases in intracellular Ca2 ([Ca2]i) in the vascular
wall (fura 2 fluorescence) and phosphorylation of PKC (Western blotting). The PKC activator phorbol myristate
acetate significantly increased vascular O2· production, which was inhibited by superoxide dismutase, diphenylenei-
odonium, chelerythrine, or removal of extracellular Ca2. Both high Pi and phorbol myristate acetate increased the
phosphorylation of the NAD(P)H oxidase subunit p47phox.
Conclusion—High Pi itself elicits arterial O2· production, most likely by PKC-dependent activation of NAD(P)H oxidase,
thus providing a potential explanation for the presence of oxidative stress and endothelial dysfunction in various forms
of hypertension and the vasculoprotective effect of antihypertensive agents of different mechanisms of action.
(Circulation. 2003;108:1253-1258.)
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Numerous studies in humans1 and animals2–6 suggest thatincreased superoxide (O2·) production contributes signifi-
cantly to the functional alterations of arteries present in hyperten-
sion. In peripheral arteries and arterioles, increased levels of O2·
have been shown to decrease the bioavailability of the endotheli-
um-derived vasodilator nitric oxide to flow,6,7 thereby contributing
to the maintenance of elevated peripheral resistance. However, the
stimuli and mechanisms underlying increased O2· production in
hypertension are not completely understood.
The vascular effects of hypertension are complex and are
likely to be induced, at least in part, by increased levels of
neurohumoral factors. Among the humoral factors, angioten-
sin has been suggested to increase O2· generation in vascular
cells.3,4,8,9 However, oxidative stress seems to be present in
virtually all forms of hypertension,4,5 including low-renin
hypertension,10 despite the differences in plasma levels of
circulating factors. Importantly, in angiotensin-infused rats,
reduction of blood pressure with hydralazine or spironolac-
tone (which is unlikely to affect angiotensin levels) normal-
ized aortic O2· production.8,11 Reduction of blood pressure in
rats infused with both angiotensin and norepinephrine by
hydralazine also normalized increased plasma levels of 8-epi-
prostaglandin F2, a marker of oxidative stress in vivo.12
Thus, it is logical to hypothesize that high intraluminal
pressure (Pi) itself can also promote vascular O2· generation
in hypertension. This idea is congruent with previous obser-
vations that even short-term increases in Pi, both in vivo and
in vitro, impair endothelial function,13–16 an effect that can be
prevented by superoxide dismutase (SOD).17 However, the
possible role of high Pi alone in the upregulation of arterial
O2· production and the underlying signaling mechanisms has
not yet been elucidated.
To test the hypothesis that the presence of high Pi per se, by
activating vascular oxidases, elicits oxidative stress, we
investigated pressure-induced O2· production in isolated
arteries in vitro, a condition in which neurohumoral factors
are absent. Also, we aimed to elucidate the contribution of
possible vascular sources of O2·, including NAD(P)H oxi-
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dases,4,5 and the role of mechanosensitive pathways, such as
Ca2 and protein kinase C (PKC)– dependent signaling
mechanisms.2,3,18
Methods
Vessel Isolation and Functional Studies
Functional studies were conducted on pressurized branches of the
femoral artery (diameter, 200 m) that were isolated from male
Wistar rats (n20; 14 weeks old; Charles River Laboratories,
Wilmington, Mass), as previously described.17,19,20 At normal Pi
(80 mm Hg), flow-induced dilations were obtained; then, Pi was
increased to 160 mm Hg for 30 minutes. In other experiments,
vessels were exposed to high Pi in the presence of SOD (200 U/mL),
apocynin (3104 mol/L, a NAD(P)H oxidase inhibitor5,21), losartan
(106 mol/L, an angiotensin II type 1 receptor inhibitor), or captopril
(106 mol/L, an angiotensin-converting enzyme inhibitor). After the
high Pi exposure, Pi was returned to 80 mm Hg, and flow-induced
responses were reassessed. In separate experiments, arteries were
incubated with Ca2-free solution during high Pi treatment, then
flow-induced responses were reassessed after readministering Ca2
(at 80 mm Hg).
Measurement of Vascular O2· Levels
Proximal arterial segments were isolated and cannulated, and the
production of O2· in response to step increases in Pi (from 0 mm Hg
to 80 mm Hg or from 0 mm Hg to 160 mm Hg) was continuously
measured by the real-time lucigenin (10 mol/L) chemilumines-
cence method using a vessel-perfusion system coupled to a
photomultiplier-based detector.21 Pressure-induced changes in lu-
cigenin chemiluminescence were also measured in the presence of
diphenyleneiodonium (DPI; 105 mol/L, an inhibitor of flavoprotein-
containing oxidases, including NAD(P)H oxidases) or chelerythrine
(106 mol/L, an inhibitor of PKC and PKC-induced NAD(P)H
activity3) or in the absence of extracellular Ca2.
In separate experiments, arteries were cannulated and pressurized
to 80 mm Hg or 160 mm Hg (for 30 minutes) in the absence or
presence of SOD (200 U/mL), chelerythrine (106 mol/L), apocynin
(3104 mol/L), staurosporine (106 mol/L, an inhibitor of PKC),
Tiron (10 mmol/L, a O2· scavenger), or losartan (106 mol/L) or in
the absence of extracellular Ca2. Then, post-pressure treatment
lucigenin chemiluminescence was measured with a scintillation
counter, as previously described.22 Also, in some experiments,
lucigenin chemiluminescence was compared in arteries exposed to
80 mm Hg and 120 mm Hg. Further, arterial O2· production was
also assessed after incubation with the PKC activator phorbol
myristate acetate (PMA; 106 mol/L, for 30 minutes, at 37°C) in the
absence and presence of chelerythrine, SOD, or DPI or after removal
of extracellular Ca2. The effect of ionomycin (106 mol/L, a Ca2
ionophore) on vascular O2· levels was also determined.
Ethidium Bromide Fluorescence
Hydroethidine was used to localize pressure-induced O2· produc-
tion, as described previously.22 Identical branches of the left and
right femoral arteries were cannulated, pressurized (to 80 or
160 mm Hg), and exposed to hydroethidine (2106 mol/L, at 37°C,
for 15 minutes). They were then embedded, snap-frozen in liquid
nitrogen, and cryosectioned. The sections were immunostained for
smooth muscle -actin. We used 4,6-diamidino-2-phenylindole di-
hydrochloride (DAPI) for nuclear staining, and fluorescent images
were collected. Normal and high Pi-exposed vessels were processed
and imaged in parallel.
Measurement of Endothelial and Smooth Muscle
Intracellular Ca2
The smooth muscle or the endothelium of isolated, cannulated
arteries were loaded with the Ca2-sensitive fluorescent indicator
fura 2 acetoxy-methyl, as described previously.20 Changes in intra-
cellular Ca2 {[Ca2]i} in the arterial endothelium and smooth
muscle in response to increases in Pi (from 0 to 80 mm Hg or to
160 mm Hg) were measured by the ratiometric fluorescence method
using the Ionoptix Microfluorimeter System (Ionoptix Co).20 Re-
sponses were also reassessed in the absence of extracellular Ca2.
Detection of Pressure-Induced PKC
Phosphorylation by Western Blotting
Phosphorylation of PKC was detected by Western blotting, as
described previously.23 Arteries were cannulated in a dual-vessel
chamber (model CH/1/QT, Living System Instrumentation), pressur-
ized to 80 mm Hg or 160 mm Hg (for 30 minutes at 37°C), and then
snap-frozen in liquid nitrogen. Nonpressurized vessels served as
controls. Protein samples were prepared22,23 in the presence of
Na3VO4 (1 mmol/L) and phosphatase inhibitors (Sigma). Equal
amounts of protein (8 g) were electrophoresed on 10% SDS-PAGE
gels, and Western blotting was performed using a phosphorylation-
specific primary antibody for PKC (Cell Signalling Technology,
Beverly, Mass; 1:1000) and anti-rabbit IgG-horseradish peroxidase
secondary antibody (Amersham Biosciences, Piscataway, NJ;
1:4000). Anti--actin was used for normalization.
Immunofluorescent Labeling of Phospho-PKC
Isolated arteries pressurized to 160 mm Hg were treated with
phosphatase inhibitors, embedded, snap-frozen in liquid nitrogen,
and cryosectioned (thickness, 4 m). Immunofluorescent labeling22
was performed with phospho-specific anti-PKC primary antibody.
DAPI was used for nuclear staining.
Immunoprecipitation and Detection of
Pressure-Induced p47phox Phosphorylation by
Western Blotting
Isolated arteries were pressurized (for 30 minutes at 37°C) to 0, 80,
or 160 mm Hg or 160 mm Hg plus 106 mol/L chelerythrine or
0 mm Hg plus 106 mol/L PMA, snap-frozen in liquid nitrogen, and
lysed in a radio immunoprecipitation (RIPA) lysis buffer (Upstate
USIA Inc) containing phosphatase inhibitors. Proteins were incu-
bated with protein A beads (Amersham; 1 hour at 4°C) and with
anti-p47phox primary antibody (5 g, overnight at 4°C). Then, the
samples were centrifuged (12 000g), the pellet was washed (3
RIPA and 1 50 mmol/L Tris, pH 8.0), and the proteins were
Figure 1. A, Flow-induced dilations in rat femoral arterial branches
under control conditions (80 mm Hg) and after high Pi treatment
(160 mm Hg). B, Effect of high Pi treatment on flow (20 L/min)-
induced dilation (expressed as percentage of maximum response)
in the absence or presence of superoxide dismutase (SOD; 200
U/mL), apocynin (3104 mol/L), losartan (106 mol/L), or captopril
(106 mol/L) or in the absence of extracellular Ca2 (n4 to 12).
Data are normalized to the control mean values. *P0.05.
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separated by SDS-PAGE, transferred to membranes, and probed with
a primary antibody against phosphorylated serine residues (1:1000, 1
hour, Cell Signaling) and normalized for p47phox content.22,23
Materials
All chemicals, if otherwise not specified, were obtained from
Sigma-Aldrich Co, and solutions were prepared on the day of the
experiment. Final concentrations are reported in the text.
Data Analysis
Lucigenin chemiluminescence data and densitometric ratios were
normalized to the respective control mean values. Selective portions
of representative Western blots are shown for clarity. Data are
expressed as the meanSEM. Statistical analyses of data were
performed by Student’s t test or by 2-way ANOVA followed by the




In control conditions, increases in intraluminal flow elicited
significant dilations. These dilations were significantly re-
duced after the vessels were exposed to high Pi (Figure 1).
Previous studies demonstrated that agonist-induced nitric
oxide–mediated dilations are also impaired in vessels that
were previously exposed to high Pi in a similar manner.17
Administration of SOD or apocynin (but not losartan or
captopril) or removal of extracellular Ca2 prevented the high
Pi–induced impairment of flow-induced dilation (Figure 1).
Vascular O2· Production
Real-time lucigenin chemiluminescence measurements
showed that an increase in Pi from 0 mm Hg to 80 mm Hg
resulted in minimal changes in vascular O2· production. In
contrast, exposure to high Pi (160 mm Hg) elicited biphasic
increases in vascular O2· generation, with a rapid peak
increase followed by a plateau phase (Figures 2A and 2B).
Incubation of the vessels with DPI or chelerythrine or
removal of extracellular Ca2 prevented high Pi–induced
increases in O2· levels (Figure 2C). Scintillation counter
measurements showed that levels of O2· remained signifi-
cantly increased in vessels exposed to 160 mm Hg compared
with arteries exposed to 80 mm Hg (Figure 3A). Pressuriza-
tion of arteries to 120 mm Hg also resulted in moderate but
significant increases (144%) in O2· generation. Increased
O2· generation in high (160 mm Hg) Pi–pretreated vessels
was inhibited by cotreatment with SOD, DPI, chelerythrine,
apocynin, staurosporin, or Tiron or by removal of extracel-
lular Ca2 (Figures 3A and 3B), thus eliminating the difference
between the groups. Increased O2· generation in high Pi–treated
Figure 2. A, Original recording showing pressure-induced generation
of O2· as determined by lucigenin chemiluminescence (CL) in iso-
lated rat femoral arterial branches. Bar graphs (B) are summary data
from 5 separate experiments (*P0.05). C, Generation of O2· in the
presence of DPI (105 mol/L) or chelerythrine (106 mol/L) or in the
absence of extracellular Ca2. D, Representative fluorescent pho-
tomicrographs of the sections of rat femoral arterial branches
exposed to an intraluminal pressure of 80 or 160 mm Hg (for 30 min-
utes) in the presence of the dye dihydroethidium, which produces a
red fluorescence when oxidized to ethidium bromide (EB) by O2·.
Overlaying EB-stained fluorescent images with images of the same
vessel section stained for smooth muscle -actin (green fluores-
cence) show that increased O2· levels are present in both the
smooth muscle (arrow) and the endothelium (arrowhead) of high
pressure-exposed arteries (40; L, arterial lumen). E, Only weak EB
staining is visible in normal pressure-exposed arteries. DAPI (blue)
was used for nuclear staining.
Ungvari et al Pressure Activates NAD(P)H Oxidase Via PKC 1255
vessels was unaffected by losartan (Figure 3B). Incubation of
control arteries with PMA (for 30 minutes) significantly increased
O2· production, which could be inhibited by administration of
chelerythrine, SOD, or DPI or by removal of extracellular Ca2
(Figure 3C). The Ca2 ionophore ionomycin also significantly
increased vascular O2· generation, although its effect was smaller
than that of PMA (Figure 3C).
Hydroethidine Fluorescence
In sections of arteries exposed to 160 mm Hg, ethidium
bromide staining of nuclei was stronger than in sections of
arteries exposed to 80 mm Hg (representative ethidium
bromide fluorescent images are shown in Figures 2D and
2E). Overlaying of ethidium bromide–stained fluorescent
images (red) with images of the same vessel sections
stained for smooth muscle -actin (green) showed that
high Pi increased O2· levels in both the media and intima
of arteries (Figure 2D).
Measurement of Endothelial and Smooth
Muscle [Ca2]i
Smooth muscle [Ca2]i was significantly greater at 160 mm Hg
Pi than at 80 mm Hg Pi (Figure 4B), which corresponded to our
previous findings,20 whereas increases in Pi had only a slight
effect on [Ca2]i in the endothelium (Figure 4A). In the absence
of extracellular Ca2, both endothelial and smooth muscle
[Ca2]i were substantially decreased and were unaffected by
changes in Pi (Figures 4A and 4B).
Pressure-Induced Phosphorylation of PKC
Increases in Pi resulted in significantly increased phosphory-
lation of PKC in arteries (Figure 5A). In arteries pressurized
to 160 mm Hg, PKC phosphorylation was significantly
greater than in vessels exposed to 80 mm Hg (Figure 5A).
Immunofluorescent labeling of sections of arteries pressur-
ized to 160 mm Hg showed that phospho-PKC was predom-
inantly located in the media and the intima, whereas immu-
nostaining of the adventitia was less evident (Figure 5B).
Pressure-Induced Phosphorylation of p47phox
The phosphorylation of p47phox in isolated arteries was analyzed
by detecting phosphorylation of serine residues after p47phox
immunoprecipitation and SDS-PAGE. Pressurization of arteries
resulted in significantly increased phosphorylation of p47phox
compared with nonpressurized vessels (Figure 5C), as deter-
mined by densitometry analysis. In arteries pressurized to
160 mm Hg, p47phox phosphorylation was substantially greater
than in vessels exposed to 80 mm Hg. Chelerythrine prevented
high Pi–induced p47phox phosphorylation, whereas PMA stimu-
lation of nonpressurized vessels triggered the phosphorylation of
p47phox (Figure 5C).
Discussion
The new findings in the present study are that in high Pi–
exposed isolated arteries, there is (1) an increased chelerythrine-
and DPI-sensitive, Ca2-dependent O2· production that impairs
flow-induced nitric oxide–mediated dilation; (2) elevated
smooth muscle [Ca2]i and enhanced phosphorylation of PKC;
Figure 3. A and B, Generation of O2·, as determined by lucige-
nin chemiluminescence (CL) in isolated rat femoral arterial
branches exposed to 80 or 160 mm Hg intraluminal pressure
under control conditions or in the presence of SOD (200 U/mL),
DPI (105 mol/L), chelerythrine (Chel; 106 mol/L), apocynin
(Apo; 3104 mol/L), losartan (106 mol/L), staurosporine
(Stauro; 106 mol/L), or Tiron (10 mmol/L) or in the absence of
extracellular Ca2. C, O2· production in rat femoral arterial
branches under control conditions and in the presence of PMA
(106 mol/L), PMA in the absence of extracellular Ca2, PMA plus
chelerythrine (Chel), PMA plus DPI, PMA plus SOD, or ionomycin
(Iono; 106 mol/L). Data are normalized to the control mean value.
*P0.05 vs control, #P0.05 vs PMA alone (n4 to 5).
Figure 4. Pressure-induced changes in [Ca2]i in the arterial endo-
thelium (A) and smooth muscle (B) in the presence and absence of
extracellular Ca2. Data are meanSEM. *P0.05 (n5 to 6).
1256 Circulation September 9, 2003
and (3) enhanced chelerythrine-sensitive phosphorylation of the
p47phox subunit of NAD(P)H oxidase.
Pressure-Induced Increase in Arterial O2· Generation
In isolated arteries, SOD-reversible endothelial dysfunction could
be elicited in vitro in the absence of circulating factors by increasing
Pi to a hypertensive level (Figure 1), thus confirming our previous
findings.17 Other studies also showed that in the coronary and
cerebral circulation, short-term increases in Pi in vivo also impair
endothelial function.13–16 Mechanosensitive production of reactive
oxygen species has also been linked to pressure-induced constric-
tion of arterioles.24,25 To provide further evidence for high Pi–
induced oxidative stress, we demonstrated with real-time lucigenin
chemiluminescence measurements that high Pi itself induced sig-
nificant increases in arterial O2· generation (Figures 2A and 2B),
whereas normal levels of Pi had minimal effect. High Pi induced a
rapid peak increase in O2· production that was followed by a
plateau phase (Figure 2A). Importantly, arterial O2· levels mea-
sured after exposure to high Pi also remained elevated (Figure
3A). We have found a similar, sustained O2· generation recently
in vascular ring preparations after short-term stretching,21 thus
suggesting that mechanical activation-induced O2· production is
not readily reversible. High Pi increased vascular O2· production
in the endothelium and the smooth muscle, as shown by
ethidium bromide staining (Figure 2D), thus suggesting that
similar mechanosensitive pro-oxidant pathways are present in
both cell types.
Role of NAD(P)H Oxidase
Because high Pi–induced endothelial dysfunction (Figure 1) and
increased O2· generation (Figures 2C and 3A) could be pre-
vented by apocynin and DPI, it is likely that high Pi itself
activates NAD(P)H oxidases. The in vivo importance of high
Pi–induced activation of oxidases is supported by recent findings
showing increased NAD(P)H oxidase-dependent vascular O2·
production in virtually all forms of hypertension,2,5,7,8,26 which
can be reduced or prevented by lowering Pi.8,11 Studies on
cultured endothelial and smooth muscle cells27 and on aortic
rings21 showing stretch-induced O2· generation also suggest that
mechanosensitive pathways are coupled to NAD(P)H oxidase
activity in both the arterial endothelium and smooth muscle.
Previous studies suggested a role for locally produced angioten-
sin in vascular oxidative stress and modulation of flow-mediated
responses.28 Thus, we incubated the vessels with losartan and
captopril to exclude the contribution of a local renin-angiotensin
system, yet high Pi still activated O2· generation (Figure 3B) and
induced endothelial dysfunction (Figure 1), providing further
evidence for the direct role of high Pi.
Role of Ca2 and PKC-Dependent Signal Transduction
We found that removal of Ca2 and inhibition of PKC prevented
high Pi-induced O2· production (Figures 3A and 3B), indicating
a role for mechanosensitive Ca2 signaling and PKC-dependent
pathways in high Pi–induced upregulation of NAD(P)H oxidase
activity. This idea is consistent with the findings that high Pi
elicited significantly greater increases in smooth muscle [Ca2]i
than normal levels of Pi (Figure 4). The important role of Ca2
signaling is also supported by the finding that administration of
a Ca2 ionophore resulted in significantly increased arterial O2·
production (Figure 3C). Further, pharmacological activation of
PKC2 elicited substantial increases in arterial NAD(P)H oxidase-
derived O2· generation (Figure 3C). Because removal of Ca2
during high-pressure treatment prevented endothelial dysfunc-
Figure 5. A, Western blot analysis of
pressure-induced PKC phosphorylation
in isolated arteries. Bar graphs are sum-
mary data of normalized densitometric
ratios. (n3 to 4 vessels for each group).
Data are meanSEM. *P0.05. B, In rat
femoral arterial branches pressurized to
160 mm Hg, immunofluorescent staining
for phospho-PKC (green) was predomi-
nantly localized in the media (M) and the
intima (I), whereas immunostaining of the
adventitia (A) was less evident. L indi-
cates arterial lumen (40). DAPI (blue)
was used for nuclear staining. C, Immuno-
precipitation (IP) of the p47phox NAD(P)H
oxidase subunit from sam ples of rat fem-
oral arterial branches pressurized to 0, 80,
or 160 mm Hg under control conditions or
exposed to 160 mm Hg in the presence of
chelerythrine (Chel; 106 mol/L). Arteries
treated with PMA (106 mol/L) served as
positive controls. Phosphorylated serine
residues and total p47phox were detected
by Western blotting (IB indicates immuno-
binding). Bar graphs are summary data of
normalized densitometric ratios. (n4 ves-
sels for each group). P0.05 vs control,
#P0.05, 80 vs 160 mm Hg. D, Proposed
scheme for high pressure-induced arterial
O2· production by upregulation of Ca2-
and PKC-dependent of phosphorylation
and activation of the NAD(P)H oxidase.
Apo indicates apocynin.
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tion (Figure 1) and increases in O2· production in high Pi–
exposed arteries (Figure 3A) and phorbol ester–stimulated O2·
generation in normotensive arteries could also be reduced by
removal of Ca2 (Figure 3C), it is likely that Ca2-dependent
PKC isoforms are involved in the high Pi–induced upregulation
of arterial NAD(P)H oxidase activity. This idea is further
supported by the findings that high Pi elicited phosphorylation of
PKC23 (Figure 5A), the most abundant Ca2–dependent PKC
isoform in arteries. It seems that high Pi induces phosphorylation
and activation of PKC in both the endothelium and smooth
muscle, as indicated by immunostaining (Figure 5B) that leads
to increased O2· production in both cell types (Figure 2D).
The activity of NAD(P)H oxidases is thought to be regulated
by phosphorylation of the cytosolic regulatory p47phox subunit29
that facilitates association of the membrane-bound and cytoplas-
mic subunits of the enzyme.21 We found that high Pi substan-
tially increased phosphorylation of serine residues of p47phox, an
effect that could be prevented by inhibition of the serine/
threonine kinase PKC2,3 (Figure 5C). Correspondingly, pharma-
cological activation of PKC resulted in phosphorylation of the
p47phox subunit (Figure 5C) and increased NAD(P)H oxidase-
dependent O2· production (Figure 3C).
Thus, we conclude that hypertensive levels of Pi itself are a
sufficient stimulus for increased arterial O2· production, likely by
inducing Ca2- and PKC-dependent of phosphorylation and activa-
tion of the NAD(P)H oxidase (Figure 5D). This mechanism may
contribute to the increased O2· levels and endothelial dysfunction in
hypertension, regardless of its cause. In addition, high Pi–induced
NAD(P)H oxidase function in vivo is likely also stimulated by
increased pulsatility27,30 and/or by increased levels of humoral
factors, such as angiotensin II,3,29 that increase PKC activity via G
protein-coupled receptors. One can speculate that chronic high
Pi–induced O2· generation by stimulating redox-sensitive gene
expression also contributes to structural remodeling, because a
reduction of systemic blood pressure could reverse morphological
changes.31 Finally, our findings also provide an explanation for the
similar vasculoprotective effects of blood pressure lowering by
pharmacological treatments with different mechanisms of action
(eg, calcium antagonists, diuretics, and ACE inhibitors) in various
forms of human hypertension.
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